MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0019152
Next Gen Pharma India Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹5.8 Cr
▼ 30% YoY
Net profit · FY 2023
₹16.26 Lakh
Net margin 2.8%
EBITDA · FY 2023
₹27.51 Lakh
EBITDA margin 4.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.43 Lakh
Issued & subscribed
Open charges
₹21.73 Lakh
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
3
As per MCA filings
About Next Gen Pharma India Private Limited
Data last updated:
Next Gen Pharma India Private Limited is a private limited company based in Delhi, India, a subsidiary of Ormendes Sa. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2004PTC131754. Its GSTIN is 07AACCN0413F1Z2 (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.43 Lakh. It is led by directors including Anuja Chadha and Jeetendra Shantilalji Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 135 Pocket – C, Ifc Gazipur, Delhi, India – 110096.
As per the financials filed for FY 2023, the company reported a revenue of ₹5.8 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹16.26 Lakh (net margin 2.8%) and EBITDA of ₹27.51 Lakh (EBITDA margin 4.7%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹21.73 Lakh on record. Court records list 11 cases involving the company, including 3 filed by the company and 8 filed against it; 2 cases are pending.
Next Gen Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0019152). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nextgenlife.in.
Company details
CIN U51909DL2004PTC131754
Registration Number 131754
Incorporation Date 31 December 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Ormendes Sa
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-02-0019152
Key People
Anuja Chadha Director Jeetendra Shantilalji Jain Director Kanwaldeep Singh Chadha Director Recognitions & Rankings of Next Gen Pharma India
Contact details
Next Gen Pharma India Private Limited's registered office is in Delhi, Delhi. Its website is nextgenlife.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 135 Pocket – C, Ifc Gazipur, Delhi, India – 110096
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Next Gen Pharma India Private Limited, buy the company report.
Comprehensive company report
Next Gen Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Next Gen Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Next Gen Pharma India Private Limited, buy the company report.
Financials of Next Gen Pharma India Private Limited
FY 2025 filings availableNext Gen Pharma India Private Limited reported revenue of ₹5.8 Cr (down 30% YoY) for FY 2023.
Revenue · FY 2023
₹5.8 Cr ▼ 30%
Net profit · FY 2023
₹16.26 Lakh margin 2.8%
EBITDA · FY 2023
₹27.51 Lakh margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 34%
5 years · compounded
▼ 22%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 30%
5 years · compounded
▼ 6%
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 30% fall in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5.8 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Next Gen Pharma India Private Limited, buy the company report.
Board of directors of Next Gen Pharma India Private Limited
Next Gen Pharma India has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuja Chadha Also directs: Aanvee Healthsciences LLP | Director | 17 Jun 2021 | 5 Years 4 Months | Current |
| Jeetendra Shantilalji Jain | Director | 23 Jan 2024 | 2 Years 9 Months | Current |
| Kanwaldeep Singh Chadha Also directs: Aanvee Healthsciences LLP | Director | 15 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Next Gen Pharma India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Race Pharmaceuticals Private Limited | ₹5.82 Cr (FY 2025) | 2.0% | Chennai, Tamil Nadu, India | |||
| Aquinnova Healthcare Private Limited | ₹5.81 Cr (FY 2024) | 25.0% | Bhiwandi, Maharashtra, India | |||
| Maryus Healthcare Private Limited | ₹5.81 Cr (FY 2025) | -36.0% | Mumbai, Maharashtra, India | |||
| Next Gen Pharma India Private Limitedthis company | ₹5.8 Cr (FY 2023) | ₹16.26 Lakh | 2.8% | -30.0% | Delhi, India | |
| De Harbien Life Sciences Private Limited | ₹5.8 Cr (FY 2025) | 9.0% | Thiruvananthapuram, Kerala, India | |||
| Sundaram Pharma Private Limited | ₹5.79 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Next Gen Pharma India Private Limited, buy the company report.
Auditor
Next Gen Pharma India Private Limited is audited by MATHIA&CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MATHIA&CO. | FY 2023 | 126504W |
Shareholding
The shareholding of Next Gen Pharma India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Next Gen Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹21.73 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Mar 2023 | 100722069 | Hdfc Bank Limited | ₹21.73 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Next Gen Pharma India Private Limited has 11 court cases on record: 3 filed by Next Gen Pharma India, 8 filed against it. 2 cases are pending and 9 are disposed.
Total cases
11
Filed by the company
3
Filed against the company
8
Pending
2
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 7 | 1 |
| High courts | 2 | 1 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by CD Pharma India Private Limited | Pending |
| District court, South, Delhi | Criminal case | Filed by the company against M/S CD Pharma India Pvt. Ltd. and Ors. and 6 others | Pending |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed by the company against CD Pharma India Private Limited | Disposed |
| High Court of Delhi | Court case (FAO(OS) (COMM)) | Filed by the company against CD Pharma India Private Limited | Disposed |
| District court, South, Delhi | Revision petition | Filed against the company by C D Pharma India Private Limited | Disposed |
To see the full case history of Next Gen Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Next Gen Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Next Gen Pharma India has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCN0413F1Z2 | Delhi | Active | 01 Jul 2017 |
| 08AACCN0413F1Z0 | Rajasthan | Active | 01 Jul 2017 |
| 09AACCN0413F1ZY | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Next Gen Pharma India Private Limited, buy the company report.
Recent activity
Next Gen Pharma India Private Limited has 14 board changes on record since 2013: 3 appointments and 11 cessations. The latest: Jeetendra Shantilalji Jain ceased to be Additional Director on 29 Sep 2024.
AGM
Next Gen Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Next Gen Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Jeetendra Shantilalji Jain ceased to be Additional Director.
Ceased
Sandeep Om Prakash Juneja ceased to be Additional Director.
Appointed
Jeetendra Shantilalji Jain was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.73 Lakh with Charge ID 100722069 was registered on 09 Mar 2023.
Ceased
Anuja Chadha ceased to be Additional Director.
Appointed
Anuja Chadha was appointed as Director.
Ceased
Arun Mudgal ceased to be Additional Director.
Ceased
Kanwaldeep Singh Chadha ceased to be Additional Director.
Ceased
Praveen Malhotra ceased to be Additional Director.
Ceased
Devender Pal Singh ceased to be Director.
6 earlier events are in the company report.
Frequently asked questions
Next Gen Pharma India is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 December 2004 (22+ years old) and is registered under CIN U51909DL2004PTC131754.
Next Gen Pharma India has 3 current directors:
- Anuja Chadha - Director
- Jeetendra Shantilalji Jain - Director
- Kanwaldeep Singh Chadha - Director
The latest financial statements of Next Gen Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Next Gen Pharma India is 07AACCN0413F1Z2, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 08AACCN0413F1Z0 (Rajasthan), 09AACCN0413F1ZY (Uttar Pradesh).
The CIN (Corporate Identification Number) of Next Gen Pharma India is U51909DL2004PTC131754. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Next Gen Pharma India has 11 court cases on record: 3 filed by the company and 8 filed against it. 2 are pending. Most are in the district courts.
Next Gen Pharma India was incorporated on 31 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Next Gen Pharma India by revenue are Race Pharmaceuticals Private Limited, Aquinnova Healthcare Private Limited, Maryus Healthcare Private Limited, De Harbien Life Sciences Private Limited, Sundaram Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Jeetendra Shantilalji Jain ceased to be Additional Director on 29 Sep 2024. Sandeep Om Prakash Juneja ceased to be Additional Director on 29 Sep 2024. Jeetendra Shantilalji Jain was appointed as Director on 23 Jan 2024. Next Gen Pharma India has 14 board changes on record in total.
Yes, Next Gen Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0019152).
Next Gen Pharma India can be reached through the website nextgenlife.in. Its registered office is in Delhi, India.